# The Effect of Glutamatergic Modulation on Cocaine Self-administration

> **NCT02596022** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 18 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** CI-581a
- **DRUG:** CI-581b

## Key facts

- **NCT ID:** NCT02596022
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02596022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02596022, "The Effect of Glutamatergic Modulation on Cocaine Self-administration". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02596022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*